A Cochrane review on brain [(1)(8)F]FDG PET in dementia: limitations and future perspectives (417 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015 Sep; 42(10): 1487-1491.
Export to BibTeX Export to EndNote
Paper type: Editorial,
Impact factor: 5.537, 5-year impact factor: 5.145
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938415941&doi=10.1007%2fs00259-015-3098-2&partnerID=40&md5=452c4b818ddd7ce24d0927de5e7146b6
Keywords: Fdg-Pet, Dementia,
Affiliations:
*** IBB - CNR ***
1 Nuclear Medicine Unit, IRCCS San Martino - IST, Department of
Health Sciences, University of Genoa, Largo R. Benzi 10,
2 Department of Medical Imaging, Geneva University and Geneva
University Hospitals, Geneva, Switzerland
3 Department of Nuclear Medicine, Academic Medical Center,
University of Amsterdam, Amsterdam, The Netherlands
4 Nuclear Medicine Department, Clinica Universidad de Navarra,
University of Navarra, Pamplona, Spain
5 Inserm, U1077, Caen, France
6 Université de Caen Basse-Normandie, UMR-S1077, Caen, France
7 Ecole Pratique des Hautes Etudes, UMR-S1077, Caen, France
8 CHU de Caen, U1077, Caen, France
Klinik und Poliklinik für Nuklearmedizin, Universität zu Köln,
10 Department of Nuclear Medicine, University of Leipzig,
11 Department of Radiology & Nuclear Medicine, VU University
Medical Center, Amsterdam, The Netherlands
12 Department of Clinical Physiology, Nuclear Medicine and PET,
Copenhagen University Hospital, Rigshospitalet,
13 Institute of Biostructure and Bioimaging, CNR, Naples, Italy
14 INSERM UMR 825 Université de Toulouse; UPS; Imagerie
cérébrale et handicaps neurologiques; CHU Purpan, Place du Dr
Baylac, F-31059 Toulouse Cedex 9, France
15 Institute of Cognitive Sciences and Technologies, CNR, Rome, Italy
16 Department of Nuclear Medicine, Karolinska Hospital,
References:
Not available.
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015 Sep; 42(10): 1487-1491.
Export to BibTeX Export to EndNote
Paper type: Editorial,
Impact factor: 5.537, 5-year impact factor: 5.145
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938415941&doi=10.1007%2fs00259-015-3098-2&partnerID=40&md5=452c4b818ddd7ce24d0927de5e7146b6
Keywords: Fdg-Pet, Dementia,
Affiliations:
*** IBB - CNR ***
1 Nuclear Medicine Unit, IRCCS San Martino - IST, Department of
Health Sciences, University of Genoa, Largo R. Benzi 10,
2 Department of Medical Imaging, Geneva University and Geneva
University Hospitals, Geneva, Switzerland
3 Department of Nuclear Medicine, Academic Medical Center,
University of Amsterdam, Amsterdam, The Netherlands
4 Nuclear Medicine Department, Clinica Universidad de Navarra,
University of Navarra, Pamplona, Spain
5 Inserm, U1077, Caen, France
6 Université de Caen Basse-Normandie, UMR-S1077, Caen, France
7 Ecole Pratique des Hautes Etudes, UMR-S1077, Caen, France
8 CHU de Caen, U1077, Caen, France
Klinik und Poliklinik für Nuklearmedizin, Universität zu Köln,
10 Department of Nuclear Medicine, University of Leipzig,
11 Department of Radiology & Nuclear Medicine, VU University
Medical Center, Amsterdam, The Netherlands
12 Department of Clinical Physiology, Nuclear Medicine and PET,
Copenhagen University Hospital, Rigshospitalet,
13 Institute of Biostructure and Bioimaging, CNR, Naples, Italy
14 INSERM UMR 825 Université de Toulouse; UPS; Imagerie
cérébrale et handicaps neurologiques; CHU Purpan, Place du Dr
Baylac, F-31059 Toulouse Cedex 9, France
15 Institute of Cognitive Sciences and Technologies, CNR, Rome, Italy
16 Department of Nuclear Medicine, Karolinska Hospital,
References:
Not available.
A Cochrane review on brain [(1)(8)F]FDG PET in dementia: limitations and future perspectives
[18F]FDG PET is a well-established method for the evaluation
of patients with suspected Alzheimer's disease (AD) and other
neurodegenerative diseases [1]. This tool has the unique ability
to estimate the local cerebral metabolic rate of glucose
consumption (CMRgl), thus providing information on the distribution
of neuronal death and synapse dysfunction in vivo
[2]. Clinically, [18F]FDG PET plays a major role in the early
and differential diagnosis of dementia due to AD by showing
specific disease patterns of hypometabolism, reflecting neuronal
dysfunction in affected brain regions even in the earliest
stages of the disease [1]. However, the role of [18F]FDG PET
in identifying patients affected by AD but who are still at the
stage of mild cognitive impairment (MCI) is less established.
Although various studies have indicated a high predictive value
in this population, appropriate standardization approaches
(i.e. semiquantification methods, observer-independent analyses,
identification of cut-off values) and the value of [18F]FDG
PET in comparison to amyloidosis biomarkers are still a matter
of debate.
Recently, a Cochrane review was published with the objective
of determining the diagnostic accuracy of [18F]FDG PET
for identifying subjects with MCI who will clinically convert
toADor other dementias [3]. The authors concluded that there
is no evidence supporting routine clinical use of [18F]FDG
PET to identify those patients with MCI who will develop
AD. For several reasons, we do not agree with the authors of
this Cochrane review that existing data on the value of FDG
PET in MCI supports such a categorical conclusion. Indeed,
clear variability in diagnostic performance of [18F]FDG PET
is found in the literature, as correctly reported in the Cochrane
review. This variability, however, is not exclusively attributable
to the method itself, but rather can be explained by a
number of factors concerning study design, definitions of
MCI itself and data analysis procedures.
We would like to highlight some of these factors in greater
detail, because we believe that knowledge on these issues may
be necessary to correctly interpret the available literature and
to appreciate the diagnostic value of [18F]FDG PET in MCI.
[18F]FDG PET is a well-established method for the evaluation
of patients with suspected Alzheimer's disease (AD) and other
neurodegenerative diseases [1]. This tool has the unique ability
to estimate the local cerebral metabolic rate of glucose
consumption (CMRgl), thus providing information on the distribution
of neuronal death and synapse dysfunction in vivo
[2]. Clinically, [18F]FDG PET plays a major role in the early
and differential diagnosis of dementia due to AD by showing
specific disease patterns of hypometabolism, reflecting neuronal
dysfunction in affected brain regions even in the earliest
stages of the disease [1]. However, the role of [18F]FDG PET
in identifying patients affected by AD but who are still at the
stage of mild cognitive impairment (MCI) is less established.
Although various studies have indicated a high predictive value
in this population, appropriate standardization approaches
(i.e. semiquantification methods, observer-independent analyses,
identification of cut-off values) and the value of [18F]FDG
PET in comparison to amyloidosis biomarkers are still a matter
of debate.
Recently, a Cochrane review was published with the objective
of determining the diagnostic accuracy of [18F]FDG PET
for identifying subjects with MCI who will clinically convert
toADor other dementias [3]. The authors concluded that there
is no evidence supporting routine clinical use of [18F]FDG
PET to identify those patients with MCI who will develop
AD. For several reasons, we do not agree with the authors of
this Cochrane review that existing data on the value of FDG
PET in MCI supports such a categorical conclusion. Indeed,
clear variability in diagnostic performance of [18F]FDG PET
is found in the literature, as correctly reported in the Cochrane
review. This variability, however, is not exclusively attributable
to the method itself, but rather can be explained by a
number of factors concerning study design, definitions of
MCI itself and data analysis procedures.
We would like to highlight some of these factors in greater
detail, because we believe that knowledge on these issues may
be necessary to correctly interpret the available literature and
to appreciate the diagnostic value of [18F]FDG PET in MCI.
A Cochrane review on brain [(1)(8)F]FDG PET in dementia: limitations and future perspectives
| ▼ Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives |
A Cochrane review on brain [(1)(8)F]FDG PET in dementia: limitations and future perspectives
Other filter: ([btitle,keywords] "Dementia") AND NOT [ ...
Falanga AP, Piccialli I, Greco F, D'Errico S, Nolli MG, Borbone N, Oliviero G, Roviello GN
* Nanostructural Modulation of G-Quadruplex DNA in Neurodegeneration: Orotate Interaction Revealed Through Experimental and Computational Approaches (22 views)
Journal Of Neurochemistry, 2025 Jan 20; N/D: N/D-N/D.
Impact Factor: 4.2
View Export to BibTeX Export to EndNote
Caminiti SP, Sala A, Presotto L, Chincarini A, Sestini S, Perani D, Schillaci O, Berti V, Calcagni ML, Cistaro A, Morbelli S, Nobili F, Pappata S, Volterrani D, Gobbo CL
* Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps (347 views)
Eur J Nucl Med (ISSN: 1619-7070linking, 1619-7070print, 1619-7089electronic), 2021 Jul; 48(8): 2486-2499.
Impact Factor: 9.236
View Export to BibTeX Export to EndNote
Coppola C, Saracino D, Oliva M, Cipriano L, Puoti G, Pappata S, Di Fede G, Catania M, Ricci M, Cimini S, Giaccone G, Bonavita S, Rossi G
* Singular cases of Alzheimer's disease disclose new and old genetic "acquaintances" (278 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2021 May; 42(5): 2021-2029.
Impact Factor: 1.447
View Export to BibTeX Export to EndNote
Rendina A, Drongitis D, Donizetti A, Fucci L, Milan G, Tripodi F, Giustezza F, Postiglione A, Pappata S, Ferrari R, Bossù P, Angiolillo A, Di Costanzo A, Caiazzo M, Vitale E
* CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia (396 views)
J Neuropathol Exp Neurol (ISSN: 0022-3069linking), 2020 Jul 10; 79(8): 891-901.
Impact Factor: 3.51
View Export to BibTeX Export to EndNote
De Rosa A, Peluso S, De Lucia N, Russo P, Annarumma I, Esposito M, Manganelli F, Brunetti A, De Michele G, Pappata S
* Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease (863 views)
Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2018 Feb; 47: 80-83.
Impact Factor: 4.721
View Export to BibTeX Export to EndNote
Milan G, Napoletano S, Pappata S, Gentile MT, Colucci-d'Amato L, Della Rocca G, Maciag A, Rossetti CP, Fucci L, Puca A, Grossi D, Postiglione A, Vitale E
* GRN deletion in familial frontotemporal dementia showing association with clinical variability in 3 familial cases (504 views)
Neurobiol Aging (ISSN: 0197-4580, 1558-1497electronic, 0197-4580linking), 2017 May; 53: 193-193.
Impact Factor: 4.454
View Export to BibTeX Export to EndNote
Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappata S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L; EADC-PET Consortium
* Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting (1059 views)
Neuroimage Clin (ISSN: 2213-1582, 2213-1582electronic, 2213-1582linking), 2014 Oct 24; 6: 445-454.
Impact Factor: 2.526
View Export to BibTeX Export to EndNote
Quadri M, Fang M, Picillo M, Olgiati S, Breedveld Gj Graafland J, Wu B, Xu F, Erro R, Amboni M, Pappata S, Quarantelli M, Annesi G, Quattrone A, Chien Hf Barbosa ER, International Parkinsonism Genetics Network Oostra Ba Barone P, Wang J, Bonifati V
* Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism (778 views)
Hum Mutat (ISSN: 1059-7794, 1098-1004, 1098-1004electronic), 2013 Sep; 34(9): 1208-1215.
Impact Factor: 5.122
View Export to BibTeX Export to EndNote
Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (889 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Fragassi NA, Chiacchio L, Errichiello L, Pappata S, Tedeschi MR, Striano P, Striano S
* Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome (741 views)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Dec; 32(6): 1129-1133.
Impact Factor: 1.315
View Export to BibTeX Export to EndNote
Iavarone A, Lorè E, De Falco C, Milan G, Mosca R, Pappata S, Galeone F, Sorrentino P, Scognamiglio M, Postiglione A
* Dysexecutive performance of healthy oldest old subjects on the Frontal Assessment Battery (611 views)
Aging Clin Exp Res (ISSN: 1594-0667, 1720-8319), 2011 Oct; 23(5-6): 351-356.
Impact Factor: 1.552
View Export to BibTeX Export to EndNote
Varrone A, Halldin C
Molecular imaging of the dopamine transporter (783 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
View Export to BibTeX Export to EndNote
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (1042 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K
* EANM procedure guidelines for PET brain imaging using [18F]FDG, version (1561 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2103-2110.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Vergote J, Chalon S, Emond P, Vercouillie J, Pappata S, Guilloteau D
* New SPECT and PET dementia tracers (657 views)
Med Nucl (ISSN: 0928-1258), 2009 Mar; 33(3): 137-141.
Impact Factor: 0.155
View Export to BibTeX Export to EndNote
Postiglione A, Milan G, Pappata S
* Fronto-Temporal Dementia (427 views)
Research Progress In Alzheimer S Disease And Dementia Vol 4, 2009; 4: N/D-N/D.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Pappata S, Salvatore E, Postiglione A
* In vivo imaging of neurotransmission and brain receptors in dementia (1365 views) (PDF 332 views)
J Neuroimaging (ISSN: 1051-2284, 1051-2284linking), 2008 Apr; 18(2): 111-124.
Impact Factor: 1.811
View Export to BibTeX Export to EndNote
Milan G, Lamenza F, Iavarone A, Galeone F, Lore E, De Falco C, Sorrentino P, Postiglione A
* Frontal Behavioural Inventory in the differential diagnosis of dementia (2014 views)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2008; 117(4): 260-265.
Impact Factor: 2.317
View Export to BibTeX Export to EndNote
Postiglione A, Milan G, Pappata S, De Falco C, Lamenza F, Schiattarella V, Gallotta G, Sorrentino P, Striano S
* Fronto-temporal dementia presenting as Geschwind's syndrome (848 views)
Neurocase (ISSN: 1355-4794, 1465-3656), 2008; 14(3): 264-270.
Impact Factor: 0.918
View Export to BibTeX Export to EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (1504 views)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
View Export to BibTeX Export to EndNote
Serrano CM, Allegri RF, Caramelli P, Taragano FE, Camera L
* Mild cognitive impairment. Survey of attitudes of specialists and general physicians (987 views)
Medicina (ISSN: 0025-7680), 2007; 67(1): 19-25.
Impact Factor: 0.193
View Export to BibTeX Export to EndNote
Molko N, Pappata S, Mangin JF, Poupon F, Lebihan D, Bousser MG, Chabriat H
* Monitoring disease progression in CADASIL with diffusion magnetic resonance imaging: A study with whole brain histogram analysis (1266 views)
Stroke (ISSN: 0039-2499), 2002 Dec; 33(12): 2902-2908.
Impact Factor: 5.176
View Export to BibTeX Export to EndNote
Varrone A, Pappata S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M
* Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks (849 views) (PDF 365 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2002 Nov; 29(11): 1447-1454.
Impact Factor: 3.568
View Export to BibTeX Export to EndNote
Molko N, Pappata S, Mangin JF, Poupon C, Vahedi K, Jobert A, LeBihan D, Bousser MG, Chabriat H
* Diffusion tensor imaging study of subcortical gray matter in CADASIL (1036 views)
Stroke (ISSN: 0039-2499), 2001 Sep; 32(9): 2049-2054.
Impact Factor: 5.33
View Export to BibTeX Export to EndNote
Pappata S, Varrone A, Caraco C, Soricelli A, Brunetti A, Milan G, Postiglione A, Alfano B, Salvatore M
* Voxel-based comparison of 99mTc-HMPAO SPECT images in Alzheimer and fronto-temporal dementia revealed distinct patterns of CBF alterations (524 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
View Export to BibTeX Export to EndNote
Soricelli A, Tedeschi E, Postiglione A, Grossi D, Brunetti A, Romano M, Castelli L, Mainenti PP, Salvatore M
BRAIN PERFUSION AT REST AND DURING COGNITIVE ACTIVATION IN PATIENTS WITH DEMENTIA OF ALZHEIMERS TYPE (1311 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1994 May; 35(5): N/D-N/D.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
* Nanostructural Modulation of G-Quadruplex DNA in Neurodegeneration: Orotate Interaction Revealed Through Experimental and Computational Approaches (22 views)
Journal Of Neurochemistry, 2025 Jan 20; N/D: N/D-N/D.
Impact Factor: 4.2
View Export to BibTeX Export to EndNote
Caminiti SP, Sala A, Presotto L, Chincarini A, Sestini S, Perani D, Schillaci O, Berti V, Calcagni ML, Cistaro A, Morbelli S, Nobili F, Pappata S, Volterrani D, Gobbo CL
* Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps (347 views)
Eur J Nucl Med (ISSN: 1619-7070linking, 1619-7070print, 1619-7089electronic), 2021 Jul; 48(8): 2486-2499.
Impact Factor: 9.236
View Export to BibTeX Export to EndNote
Coppola C, Saracino D, Oliva M, Cipriano L, Puoti G, Pappata S, Di Fede G, Catania M, Ricci M, Cimini S, Giaccone G, Bonavita S, Rossi G
* Singular cases of Alzheimer's disease disclose new and old genetic "acquaintances" (278 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2021 May; 42(5): 2021-2029.
Impact Factor: 1.447
View Export to BibTeX Export to EndNote
Rendina A, Drongitis D, Donizetti A, Fucci L, Milan G, Tripodi F, Giustezza F, Postiglione A, Pappata S, Ferrari R, Bossù P, Angiolillo A, Di Costanzo A, Caiazzo M, Vitale E
* CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia (396 views)
J Neuropathol Exp Neurol (ISSN: 0022-3069linking), 2020 Jul 10; 79(8): 891-901.
Impact Factor: 3.51
View Export to BibTeX Export to EndNote
De Rosa A, Peluso S, De Lucia N, Russo P, Annarumma I, Esposito M, Manganelli F, Brunetti A, De Michele G, Pappata S
* Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease (863 views)
Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2018 Feb; 47: 80-83.
Impact Factor: 4.721
View Export to BibTeX Export to EndNote
Milan G, Napoletano S, Pappata S, Gentile MT, Colucci-d'Amato L, Della Rocca G, Maciag A, Rossetti CP, Fucci L, Puca A, Grossi D, Postiglione A, Vitale E
* GRN deletion in familial frontotemporal dementia showing association with clinical variability in 3 familial cases (504 views)
Neurobiol Aging (ISSN: 0197-4580, 1558-1497electronic, 0197-4580linking), 2017 May; 53: 193-193.
Impact Factor: 4.454
View Export to BibTeX Export to EndNote
Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappata S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L; EADC-PET Consortium
* Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting (1059 views)
Neuroimage Clin (ISSN: 2213-1582, 2213-1582electronic, 2213-1582linking), 2014 Oct 24; 6: 445-454.
Impact Factor: 2.526
View Export to BibTeX Export to EndNote
Quadri M, Fang M, Picillo M, Olgiati S, Breedveld Gj Graafland J, Wu B, Xu F, Erro R, Amboni M, Pappata S, Quarantelli M, Annesi G, Quattrone A, Chien Hf Barbosa ER, International Parkinsonism Genetics Network Oostra Ba Barone P, Wang J, Bonifati V
* Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism (778 views)
Hum Mutat (ISSN: 1059-7794, 1098-1004, 1098-1004electronic), 2013 Sep; 34(9): 1208-1215.
Impact Factor: 5.122
View Export to BibTeX Export to EndNote
Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (889 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Fragassi NA, Chiacchio L, Errichiello L, Pappata S, Tedeschi MR, Striano P, Striano S
* Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome (741 views)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Dec; 32(6): 1129-1133.
Impact Factor: 1.315
View Export to BibTeX Export to EndNote
Iavarone A, Lorè E, De Falco C, Milan G, Mosca R, Pappata S, Galeone F, Sorrentino P, Scognamiglio M, Postiglione A
* Dysexecutive performance of healthy oldest old subjects on the Frontal Assessment Battery (611 views)
Aging Clin Exp Res (ISSN: 1594-0667, 1720-8319), 2011 Oct; 23(5-6): 351-356.
Impact Factor: 1.552
View Export to BibTeX Export to EndNote
Varrone A, Halldin C
Molecular imaging of the dopamine transporter (783 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
View Export to BibTeX Export to EndNote
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (1042 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K
* EANM procedure guidelines for PET brain imaging using [18F]FDG, version (1561 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2103-2110.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Vergote J, Chalon S, Emond P, Vercouillie J, Pappata S, Guilloteau D
* New SPECT and PET dementia tracers (657 views)
Med Nucl (ISSN: 0928-1258), 2009 Mar; 33(3): 137-141.
Impact Factor: 0.155
View Export to BibTeX Export to EndNote
Postiglione A, Milan G, Pappata S
* Fronto-Temporal Dementia (427 views)
Research Progress In Alzheimer S Disease And Dementia Vol 4, 2009; 4: N/D-N/D.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Pappata S, Salvatore E, Postiglione A
* In vivo imaging of neurotransmission and brain receptors in dementia (1365 views) (PDF 332 views)
J Neuroimaging (ISSN: 1051-2284, 1051-2284linking), 2008 Apr; 18(2): 111-124.
Impact Factor: 1.811
View Export to BibTeX Export to EndNote
Milan G, Lamenza F, Iavarone A, Galeone F, Lore E, De Falco C, Sorrentino P, Postiglione A
* Frontal Behavioural Inventory in the differential diagnosis of dementia (2014 views)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2008; 117(4): 260-265.
Impact Factor: 2.317
View Export to BibTeX Export to EndNote
Postiglione A, Milan G, Pappata S, De Falco C, Lamenza F, Schiattarella V, Gallotta G, Sorrentino P, Striano S
* Fronto-temporal dementia presenting as Geschwind's syndrome (848 views)
Neurocase (ISSN: 1355-4794, 1465-3656), 2008; 14(3): 264-270.
Impact Factor: 0.918
View Export to BibTeX Export to EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (1504 views)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
View Export to BibTeX Export to EndNote
Serrano CM, Allegri RF, Caramelli P, Taragano FE, Camera L
* Mild cognitive impairment. Survey of attitudes of specialists and general physicians (987 views)
Medicina (ISSN: 0025-7680), 2007; 67(1): 19-25.
Impact Factor: 0.193
View Export to BibTeX Export to EndNote
Molko N, Pappata S, Mangin JF, Poupon F, Lebihan D, Bousser MG, Chabriat H
* Monitoring disease progression in CADASIL with diffusion magnetic resonance imaging: A study with whole brain histogram analysis (1266 views)
Stroke (ISSN: 0039-2499), 2002 Dec; 33(12): 2902-2908.
Impact Factor: 5.176
View Export to BibTeX Export to EndNote
Varrone A, Pappata S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M
* Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks (849 views) (PDF 365 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2002 Nov; 29(11): 1447-1454.
Impact Factor: 3.568
View Export to BibTeX Export to EndNote
Molko N, Pappata S, Mangin JF, Poupon C, Vahedi K, Jobert A, LeBihan D, Bousser MG, Chabriat H
* Diffusion tensor imaging study of subcortical gray matter in CADASIL (1036 views)
Stroke (ISSN: 0039-2499), 2001 Sep; 32(9): 2049-2054.
Impact Factor: 5.33
View Export to BibTeX Export to EndNote
Pappata S, Varrone A, Caraco C, Soricelli A, Brunetti A, Milan G, Postiglione A, Alfano B, Salvatore M
* Voxel-based comparison of 99mTc-HMPAO SPECT images in Alzheimer and fronto-temporal dementia revealed distinct patterns of CBF alterations (524 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
View Export to BibTeX Export to EndNote
Soricelli A, Tedeschi E, Postiglione A, Grossi D, Brunetti A, Romano M, Castelli L, Mainenti PP, Salvatore M
BRAIN PERFUSION AT REST AND DURING COGNITIVE ACTIVATION IN PATIENTS WITH DEMENTIA OF ALZHEIMERS TYPE (1311 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1994 May; 35(5): N/D-N/D.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
26 Records (23 excluding Abstracts).
Total impact factor: 110.327 (103.372 excluding Abstracts).
Total 5 year impact factor: 106.244 (96.185 excluding Abstracts).
Total impact factor: 110.327 (103.372 excluding Abstracts).
Total 5 year impact factor: 106.244 (96.185 excluding Abstracts).
417 views. Last view on Friday 21 March 2025, 11:16:33
ibb.cnr.it
